Together we will beat cancer

Donate

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

Read More

Cancer vaccines – where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever?

Read More

Feeling the pull: Using magnetic drug targeting to improve chemotherapy in brain tumours

Researchers at the University of Sheffield have developed a new magnetic device we could use to make more chemotherapy drugs effective against brain tumours.

Read More

Better together: improving brain tumour treatment

We’ve helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

Read More

Hiding in plain sight: How we can use immune cells to deliver cancer-killing viruses to tumours

Researchers have found a way to deliver cancer-killing viruses to tumours by hiding them inside immune cells.

Read More

Chemo before surgery helps stop colon cancer coming back

Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.

Read More

Women in science: Cancer research pioneers – part 1

As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

Read More

Breaking the silence: when cancer steals your voice

This entry is part 6 of 9 in the series Regional Stories

Dinny and Loren had different types of cancer, and in both cases the disease took away their voices. Until, of course, they found a way to break the silence.

Read More

First-of-its-kind app for patients on clinical trials being piloted by Cancer Research UK

Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.  

Read More

NICE recommends pembrolizumab for 1,600 more people with breast cancer

The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

Read More